18F-NaF PET/CT and Extraordinary Involvement: Non-calcific Brain Involvement in a Prostate Cancer Case

Journal Title: Molecular Imaging and Radionuclide Therapy - Year 2020, Vol 29, Issue 1

Abstract

With the increase in the diagnosis of the cancer, the frequency of using imaging methods for diagnosis and for staging is also increased. Because of the complex structure of cancer and tumor behavior, the assessment methods have been updated and metabolic imaging has gained weight. The most popular of these techniques is hybrid positron emission tomography/computed tomography (PET/CT) systems. Prostate cancer is the second most common cancer in the world, is the fifth common type in cancer-related male deaths. Estimation of prognosis and treatment planning of the patients are based on the TNM classification. Bone metastasis is a prognostic factor of morbidity and mortality in prostate cancer. Sodium fluoride (NaF) PET/CT is a promising imaging modality in evaluation of skeletal system. This article will review the involvement of 18F-NaF in extra-osseous tissues in the prostate cancer and reveal the fundamental differences between 18F-NaF imaging and 18F-FDG imaging in these areas.

Authors and Affiliations

Ulku Korkmaz, Funda Ustun

Keywords

Related Articles

18F-NaF PET/CT and Extraordinary Involvement: Non-calcific Brain Involvement in a Prostate Cancer Case

With the increase in the diagnosis of the cancer, the frequency of using imaging methods for diagnosis and for staging is also increased. Because of the complex structure of cancer and tumor behavior, the assessment meth...

Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging

Vasculitis is a multisystem disease characterized by inflammation with infiltration of leukocytes into the blood vessels. Giant cell arteritis (GCA) is the most common form of vasculitis that mostly affects medium- and l...

Findings of Gynecomastia That Developed in Follow-up Secondary to Bicalutamide Treatment on Bone Scan

Prostate cancer is a common neoplastic disease especially in elder patients. Metastatic prostate disease has low five-year survival rate. Bicalutamide is an androgen receptor antagonist that acts as an inhibitor by compe...

The Prognostic Value of 18F-FDG PET/CT and KRAS Mutation in Colorectal Cancers

Objective: Prognostic effect of KRAS mutation and side of tumor in colorectal cancer is a highly controversial subject. Therefore, we evaluated the association between FDG uptake pattern in 18F-fluoro-2-deoxy-glucose pos...

Download PDF file
  • EP ID EP684465
  • DOI 10.4274/mirt.galenos.2019.85547
  • Views 158
  • Downloads 0

How To Cite

Ulku Korkmaz, Funda Ustun (2020). 18F-NaF PET/CT and Extraordinary Involvement: Non-calcific Brain Involvement in a Prostate Cancer Case. Molecular Imaging and Radionuclide Therapy, 29(1), -. https://europub.co.uk/articles/-A-684465